We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 3,767 results
  1. Von Hippel-Lindau Disease A Comprehensive Guide to Diagnosis, Treatment, and Management

    Von Hippel-Lindau (VHL) disease is an inherited disorder characterized by the abnormal growth of both benign and cancerous tumors and cysts in many...

    Dhaval Thakor Patel, Amit Tirosh
    Book 2024
  2. Neurofibromatosis type1, type 2, tuberous sclerosis and Von Hippel-Lindau disease

    Neurocutaneous syndromes (also known as phakomatoses) are heterogenous group of disorders that involve derivatives of the neuroectoderm. Each disease...

    M. Elbeltagy, M. Abbassy in Child's Nervous System
    Article 11 October 2023
  3. Epidemiology and economic burden of Von Hippel-Lindau Disease-associated central nervous system hemangioblastomas and pancreatic neuroendocrine tumors in the United States

    Background

    To date, real-world evidence around the clinical and economic burden related to von Hippel-Lindau (VHL) disease is limited. Therefore, this...

    Eric Jonasch, Yan Song, ... Murali Sundaram in Orphanet Journal of Rare Diseases
    Article Open access 16 February 2024
  4. Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma

    The distinct pathological and molecular features of kidney cancer in adaptation to oxygen homeostasis render this malignancy an attractive model for...

    Chengheng Liao, Lianxin Hu, Qing Zhang in Nature Reviews Urology
    Article 02 May 2024
  5. Surgical resection of double advanced pancreatic neuroendocrine tumors with multiple renal cell carcinoma associated with von Hippel–Lindau disease

    Von Hippel–Lindau (VHL) disease, an autosomal dominant genetic disorder caused by a germline mutation, is associated with non-functional and...

    Yoshiyuki Shibata, Takeshi Sudo, ... Hirotaka Tashiro in Clinical Journal of Gastroenterology
    Article 02 May 2024
  6. When rare diseases crisscross within the same patient: von Hippel-Lindau and type 1 gastric neuroendocrine tumor

    Von-Hippel-Lindau (VHL) is a genetic multisystem disorder characterized by visceral cysts and benign and malignant tumors in various organs. Herein,...

    Krystallenia I. Alexandraki, Ariadni Spyroglou, ... Manousos Konstadoulakis in Hormones
    Article Open access 15 April 2024
  7. Germline variants in the Von Hippel-Lindau tumor suppressor gene in Cuban patients

    Background

    Von Hippel-Lindau (VHL) syndrome is an autosomal dominantly inherited disorder that predisposes to multiple neoplasms. Patients may develop...

    Antonio Alejandro Esperón Álvarez, Inés Virginia Noa Hechavarría, ... Teresa Collazo Mesa in Egyptian Journal of Medical Human Genetics
    Article Open access 20 March 2024
  8. Screening and surveillance recommendations for central nervous system hemangioblastomas in pediatric patients with Von Hippel-Lindau disease

    Purpose

    Von Hippel-Lindau (VHL) disease is an autosomal-dominantly inherited tumor predisposition syndrome. One of the most common tumors are central...

    Anna Laura Knoblauch, B.-I. Blaß, ... J.-H. Klingler in Journal of Neuro-Oncology
    Article Open access 22 April 2024
  9. 68Ga-DOTANOC PET/CT for Screening and Surveillance of Von Hippel-Lindau (VHL) disease

    Purpose

    Hereditary tumor syndrome Von Hippel-Lindau (VHL) disease is characterized by various benign and malignant tumors that are known to express...

    Shamim Ahmed Shamim, Geetanjali Arora, ... Chandrasekhar Bal in Nuclear Medicine and Molecular Imaging
    Article 05 July 2023
  10. Familial multiple sclerosis in patients with Von Hippel-Lindau disease

    Background

    Multiple sclerosis (MS) is a progressive autoimmune demyelinating disorder. Recent studies suggest that a combination of genetic...

    Samir R. Nath, Prabhjot Grewal, ... Yang Mao-Draayer in BMC Neurology
    Article Open access 08 March 2022
  11. Von Hippel–Lindau syndrome with a rare complication of dilated cardiomyopathy: a case report

    Background

    Von Hippel Lindau (VHL) syndrome is an autosomal dominant hereditary disease affecting multiple organs, with pheochromocytoma in 26% of...

    Ming Yu, Beibei Du, ... ** Yang in BMC Cardiovascular Disorders
    Article Open access 18 November 2022
  12. Mutation in Chek2 triggers von Hippel-Lindau hemangioblastoma growth

    Purpose

    Von Hippel-Lindau (VHL) is a rare inherited disease mainly characterized by the growth of tumours, predominantly hemangioblastomas (Hbs) in...

    Jorge Cabrera-Montes, Daniel T. Aguirre, ... Angel M. Cuesta in Acta Neurochirurgica
    Article Open access 16 October 2023
  13. An Amazing Image of Von Hippel–Lindau Syndrome

    A 49-year-old woman presented with a 2-week history of painless jaundice and pruritus. She had a medical history of three surgical excisions of...

    Xu Wang, Zhong Xu, Wei-Feng Huang in Indian Journal of Surgery
    Article 21 May 2022
  14. Management of Pregnancy in a Case of Endolymphatic Sac Tumour as a Part of Von Hippel–Lindau Syndrome Complex: A Case Report and Review of Literature

    Endolymphatic sac tumor (ELST) is a rare (1/30000) neoplasm with less than 200 cases reported. It is seen in 24–30% of patients with Von...

    Rao Preethi Venkatachala, Shashikala Karanth in The Journal of Obstetrics and Gynecology of India
    Article 22 December 2023
  15. Hemangioblastoma and mosaic von Hippel Lindau disease: rare presentation and review of the literature

    Hemangioblastomas are benign vascular tumors that can occur throughout the central nervous system (CNS) sporadically or in association with von...

    Abbie Whitman, Sudarshawn Damodharan, ... Bermans Iskandar in Child's Nervous System
    Article 28 January 2023
  16. The outcome of central nervous system hemangioblastomas in Von Hippel-Lindau (VHL) disease treated with belzutifan: a single-institution retrospective experience

    Purpose

    Belzutifan is a Hypoxia Inducible Factor 2-alpha inhibitor approved in 2021 by the FDA for the treatment of renal cell carcinoma (RCC) in...

    Aroosa Zamarud, Neelan J. Marianayagam, ... Steven D. Chang in Journal of Neuro-Oncology
    Article 13 November 2023
  17. Tumor-to-tumor metastasis of colon cancer metastasizing to a pancreatic neuroendocrine tumor associated with von Hippel-Lindau disease: a case report

    Von Hippel-Lindau disease (VHL) is frequently associated with pancreatic neuroendocrine tumors (PNETs). Here, we report a case of tumor-to-tumor...

    Hiroki Natsui, Junji Kohisa, ... Shuji Terai in Clinical Journal of Gastroenterology
    Article Open access 11 August 2022
  18. 68Ga-DOTATATE Avid Metastatic Vertebral Renal Cell Carcinoma in the Setting of von Hippel-Lindau Syndrome

    Although rare, a metastatic renal cell carcinoma could present with 68 Ga-DOTATATE avidity. A 66-year-old man with von Hippel-Lindau syndrome (VHL)...

    Mayank Patel, Abhishek Jha, ... Karel Pacak in Nuclear Medicine and Molecular Imaging
    Article 27 July 2022
  19. Combined therapy guided by multimodal imaging of fifteen retinal capillary hemangioblastomas in a monocular Von Hippel- Lindau syndrome case report

    Background

    To report the multimodal imaging and treatment of fifteen retinal capillary hemangioblastomas (RCHs)...

    Ju Guo, Li** Du, ... Xuemin ** in BMC Ophthalmology
    Article Open access 06 May 2022
Did you find what you were looking for? Share feedback.